DJIA 16,380.41 263.17 1.63%
NASDAQ 4,258.44 41.05 0.97%
S&P 500 1,886.76 24.00 1.29%
market minute promo

Exelixis (NASDAQ: EXEL)

1.58 -0.05 (-2.78%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXEL $1.58 -2.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.68
Previous Close $1.62
Daily Range $1.55 - $1.68
52-Week Range $1.35 - $8.41
Market Cap $307.3M
P/E Ratio -1.07
Dividend (Yield) $0.00 (0.0%)
Volume 1,287,799
Average Daily Volume 4,094,758
Current FY EPS -$1.49





Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary Rss Feed

Is Exelixis, Inc. Stock a Bad News Buy?

Is the 75% drop in Exelixis, Inc. stock justified? Two of our top analysts weigh in and discuss the company's potential as a "bad news buy".

3 Biotech Stocks Near 52-Week Lows Worth Buying

These may be cheap biotech stocks, but they may not be cheap for long according to the three analysts we asked.

Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog

Exelixis (EXEL) Is in Oversold Territory: What's Next? - Tale of the Tape

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

Why Exelixis, Inc. Stock Is Soaring Today

Shares of small-cap biopharma Exelixis Inc. are up big today. Here's why.

Update: Exelixis Announces Very Positive Results From The CoBRIM Trial - Impacts To My Bull Thesis

Morning Market Movers

5-year lows: National Presto Industries, Ennis Inc, Landauer Inc, and Exelixis Inc.

Why Exelixis (EXEL) Stock Might be a Great Pick - Tale of the Tape

See More EXEL News...

EXEL's Top Competitors

EXEL $1.58 (-2.78%)
Current stock: EXEL
TMO $112.36 (2.43%)
Current stock: TMO
ILMN $164.91 (2.92%)
Current stock: ILMN
WAT $96.98 (1.96%)
Current stock: WAT